Evidence map›Paper›PMID 22666523›Full record

ReviewOxidative medicine and cellular longevity2012

Anticancer activity of green tea polyphenols in prostate gland.

Pierpaola Davalli, Federica Rizzi, Andrea Caporali, Davide Pellacani, Serena Davoli, Saverio Bettuzzi, Maurizio Brausi, Domenico D'Arca

Open access · hybridAbstract readReview
In one paragraph

Review in Oxidative medicine and cellular longevity, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
5.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 66 citations in OpenAlex.

  1. Review
  2. Tea andChinese herbal medicines · 2022
    Article
  3. Article
  4. Molecular Mechanisms and Bioavailability of Polyphenols in Prostate Cancer.International journal of molecular sciences · 2019
    Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Dietary Antioxidant and Flavonoid Intakes Are Reduced in the Elderly.Oxidative medicine and cellular longevity · 2015
    Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 7 institutions in 3 countries.

Pierpaola DavalliDepartment of Biomedical Sciences, University of Modena & Reggio Emilia, 41121 Modena, Italy.
Federica Rizzi
Andrea Caporali
Davide Pellacani
Serena Davoli
Saverio Bettuzzi
Maurizio Brausi
Domenico D'Arca
University of Parma · ITInstitut de génétique et de biologie moléculaire et cellulaire · FRIstituto Nazionale Biostrutture e Biosistemi · ITIstituto Ramazzini · ITUniversity of Bristol · GBUniversity of Modena and Reggio Emilia · ITUniversity of York · GB

Funding

British Heart Foundation FS/11/52/29018
6 · The paper itself

Abstract

Numerous evidences from prevention studies in humans, support the existence of an association between green tea polyphenols consumption and a reduced cancer risk. Prostate cancer is one of the most frequently diagnosed male neoplasia in the Western countries, which is in agreement with this gland being particularly vulnerable to oxidative stress processes, often associated with tumorigenesis. Tea polyphenols have been extensively studied in cell culture and animal models where they inhibited tumor onset and progression. Prostate cancer appears a suitable target for primary prevention care, since it grows slowly, before symptoms arise, thus offering a relatively long time period for therapeutic interventions. It is, in fact, usually diagnosed in men 50-year-old or older, when even a modest delay in progression of the disease could significantly improve the patients quality of life. Although epidemiological studies have not yet yielded conclusive results on the chemopreventive and anticancer effect of tea polyphenols, there is an increasing trend to employ these substances as conservative management for patients diagnosed with less advanced prostate cancer. Here, we intend to review the most recent observations relating tea polyphenols to human prostate cancer risk, in an attempt to outline better their potential employment for preventing prostate cancer.

Indexed as

AnimalsAnticarcinogenic AgentsDrug Screening Assays, AntitumorHumansMalePolyphenolsProstateProstatic NeoplasmsTeaAnticarcinogenic AgentsPolyphenolsTea

Identifiers

PMID22666523
PMCPMC3362217
OpenAlexW2100052188

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.